Dr Eleanor Neal
Honorary (Fellow)
Department of Paediatrics
14 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Association between village coverage of 13-valent pneumococcal conjugate vaccine and vaccine-type pneumococcal carriage among children aged 0–59 months with pneumonia in Papua New Guinea: an observational study
DOI: 10.1016/j.jvacx.2026.1008112026
Research grants (international)
Developing a Budget Optimisation Framework to Evaluate PCV Vaccination Strategies Under Constrained Financing in LMICs: A Comparative Analysis of Lower-Cost Products, Reduced Schedules, and Fractional Dosing
2026
Journal article
Cellular immune responses 12 months after fractional or standard dose BNT162b2 booster vaccination in Mongolian adults
DOI: 10.3389/fimmu.2026.17794352026
Journal article
SARS-CoV-2 infection patterns and immune responses by fourth-dose COVID-19 vaccination status
DOI: 10.1016/j.anzjph.2026.1004892026
Journal article
Effect of time-of-day vaccination on the antibody response to mRNA and protein COVID-19 vaccine in adults
DOI: 10.1016/j.vaccine.2026.1285742025
Journal article
The safety and efficacy of a single dose of oral azithromycin given in labour to prevent skin and soft tissue infections in young infants in Fiji: a randomised controlled trial
DOI: 10.1186/s12916-025-04070-62025
Journal article
Immunogenicity and safety at twelve months of fractional and standard BNT162b2 booster doses in adults primed with ChAdOx1-S, BBIBP-CorV, or Gam-COVID-Vac in Mongolia: a randomised controlled trial
DOI: 10.1016/j.vaccine.2025.127840
RECENT SCHOLARLY WORKS
2025
Journal article
The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose
DOI: 10.1016/j.jinf.2025.1064472025
Journal article
Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trial
DOI: 10.1038/s41467-025-63598-62024
Journal article
Immunogenicity, safety, and reactogenicity of a halfversus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial
DOI: 10.1016/j.lanwpc.2023.1009532021
Journal article
Delayed or failure to follow-up abnormal breast cancer screening mammograms in primary care: a systematic review
DOI: 10.1186/s12885-021-08100-3